| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $48.5M | -57.7% |
| R&D Expense | $174.1M | +25.7% |
| SG&A Expense | $37.6M | +4.1% |
| Operating Income | -$170.7M | -184.9% |
| Pre-tax Income | -$170.5M | -206.4% |
| Income Tax | -$88K | -109.9% |
| Net Income | -$170.4M | -201.4% |
| EPS (Basic) | -$0.75 | -200.0% |
| EPS (Diluted) | -$0.75 | -200.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.7M | -18.1% |
| Short-term Investments | $99.2M | -60.1% |
| Accounts Receivable | $12.2M | +129.1% |
| Current Assets | $167.6M | -45.9% |
| Total Assets | $172.2M | -45.4% |
| Current Liabilities | $63.4M | +40.9% |
| Total Liabilities | $295.0M | +3.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$171.3M | -4838.5% |
| Capital Expenditures | $79K | — |
| Investing Cash Flow | $156.4M | +438.7% |
| Financing Cash Flow | $6.4M | +155.9% |
| Free Cash Flow | -$171.3M | -4840.7% |
| -$122.8M |
| -516.2% |